Kellerhals Carrard acted as legal advisor to STILLE in this transaction.
Stille AB, a medical device company whose shares are listed on the Nasdaq First North Growth Market, has acquired all shares in Switzerland-based S & T AG (S & T) in exchange for CHF 6 million paid in cash, CHF 2.5 million paid in STILLE shares and, in addition, a possible further contingent consideration of maximum CHF 3 million on 8 July 2021.
The Germany-based sister Company S&T GmbH, whose primary function has been to facilitate the export of products from S & T to the EU, is also part of the acquisition for a purchase price of EUR 25,000. S & T will become a part of STILLE’s business area Surgical Instruments.
STILLE is one of the world’s oldest medical device companies and a high-quality manufacturer of surgical instruments in the premium segment. STILLE’s main business areas are surgical instruments and c-arm tables mostly used during different kinds of open surgery and minimal invasive procedures.
S&T is one of the world’s leading manufacturer of high-quality microsurgical instruments, which are marketed through around 50 distributors around the world, with the US, the UK and Germany as the most important markets.
The Kellerhals Carrard team was led by partner Dr. Emanuel Dettwiler (Picture – Corporate/M&A) and comprised senior associates Sophie Holdt (Corporate/M&A), Dr. Melanie Huber (Employment), Laura Manz (Insurance) and Marco Sibold (Taxes) as well as associates Jon Oetiker and Larissa Simeon (both Corporate/M&A).
Involved fees earner: Emanuel Dettwiler – Kellerhals Carrard; Sophie Holdt – Kellerhals Carrard; Melanie Huber – Kellerhals Carrard; Laura Manz – Kellerhals Carrard; Jon Oetiker – Kellerhals Carrard; Marco Sibold – Kellerhals Carrard; Larissa Simeon – Kellerhals Carrard;
Law Firms: Kellerhals Carrard;
Clients: Stille AB;